BSE - Delayed Quote INR

Hester Biosciences Limited (HESTERBIO.BO)

Compare
1,725.55
-41.95
(-2.37%)
At close: 3:28:00 PM GMT+5:30
Loading Chart for HESTERBIO.BO
DELL
  • Previous Close 1,767.50
  • Open 1,799.00
  • Bid 1,739.00 x --
  • Ask 1,753.55 x --
  • Day's Range 1,720.00 - 1,824.00
  • 52 Week Range 1,292.90 - 3,375.45
  • Volume 226
  • Avg. Volume 1,019
  • Market Cap (intraday) 14.679B
  • Beta (5Y Monthly) 0.70
  • PE Ratio (TTM) 46.71
  • EPS (TTM) 36.94
  • Earnings Date May 8, 2025 - May 12, 2025
  • Forward Dividend & Yield 6.00 (0.29%)
  • Ex-Dividend Date Aug 22, 2024
  • 1y Target Est --

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers livestock vaccines for goat pox, peste des petits ruminants, brucella abortus, contagious bovine pleuropneumonia, CCPP, and lumpy skin diseases; and diagnostic services. In addition, the company provides animal healthcare products, such as biosecurity solutions, therapeutic treatment, herbal supplements, homeopathic remedies, and feed supplements. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticides, coat nutrition, grooming aids, and anti-infective formulations. Additionally, the company provides seroprofiling kits; diagnostic labs for poultry flocks; and mastitis control programs for cattle; as well as engages in manufacturing and trading of goods. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.

www.hester.in

642

Full Time Employees

March 31

Fiscal Year Ends

Recent News: HESTERBIO.BO

View More

Performance Overview: HESTERBIO.BO

Trailing total returns as of 2/13/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

HESTERBIO.BO
27.91%
S&P BSE SENSEX
2.56%

1-Year Return

HESTERBIO.BO
21.81%
S&P BSE SENSEX
6.41%

3-Year Return

HESTERBIO.BO
27.84%
S&P BSE SENSEX
30.93%

5-Year Return

HESTERBIO.BO
16.69%
S&P BSE SENSEX
83.65%

Compare To: HESTERBIO.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HESTERBIO.BO

View More

Valuation Measures

As of 2/12/2025
  • Market Cap

    15.04B

  • Enterprise Value

    17.12B

  • Trailing P/E

    47.88

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.93

  • Price/Book (mrq)

    4.98

  • Enterprise Value/Revenue

    5.55

  • Enterprise Value/EBITDA

    26.17

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.42%

  • Return on Assets (ttm)

    4.74%

  • Return on Equity (ttm)

    8.68%

  • Revenue (ttm)

    3.16B

  • Net Income Avi to Common (ttm)

    234.69M

  • Diluted EPS (ttm)

    36.94

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    167.88M

  • Total Debt/Equity (mrq)

    77.65%

  • Levered Free Cash Flow (ttm)

    252.18M

Research Analysis: HESTERBIO.BO

View More

People Also Watch